Onkure Therapeutics Inc-A

Penny Stocks Biotech Stocks Healthcare Stocks

$3.40

+0.01 (+0.30%)

As of May 16, 2:23 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +517.6% upside

Low Target $13.91

Average Target $21.00

High Target $28.26

Current Price $3.40

Current
$3.40

Target
$21.00

$13.91 $21.00 avg $28.26

Scenario Analysis

Bear Case

$13.91

309.1%

Low target

Base Case

$21.00

+517.6%

Avg target

Bull Case

$28.26

+731.2%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$5.38

-36.8% from high

52-Week Low

$1.77

+92.1% from low

Target vs 52W High

$21.00

+290.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%